Neuropathological analysis in spinal muscular atrophy type II

Area of Science:

• Neuropathology
• Neurodegenerative diseases
• Molecular biology

Background:

• Infantile spinal muscular atrophy (SMA) type II is a severe neurodegenerative disorder affecting motor neurons.
• Understanding the molecular mechanisms of neurodegeneration in SMA type II is crucial for developing effective therapies.

Purpose of the Study:

• To investigate the neuropathological features and molecular pathways involved in neurodegeneration in two cases of SMA type II.
• To differentiate the pathological mechanisms in SMA type II from those observed in SMA type I.

Main Methods:

• Neuropathological analysis including in situ nick end labeling (ISEL) and immunohistochemistry.
• Assessment of motor neuron loss, gliosis, apoptosis markers (ISEL, Bcl-x), neurofilament and synaptophysin expression, oxidative stress markers (8-hydroxy-2'-deoxyguanosine), and glial glutamate transporters.

Main Results:

• Severe reduction of spinal cord and brain stem motor neurons and gliosis observed.
• Spared Clark's and lateral thalamic nuclei, but reduced Betz cells and lateral funiculus myelinated fibers.
• Evidence of oxidative stress and mild apoptosis in the younger case; normal neurofilament expression and mild synaptophysin reduction.

Conclusions:

• Oxidative stress and apoptosis are implicated in SMA type II neurodegeneration.
• Neurofilament metabolism and excitotoxicity are less likely to be primary drivers of pathology in SMA type II.
• Findings suggest distinct molecular mechanisms contribute to neurodegeneration in different SMA types.